Matches in Wikidata for { <http://www.wikidata.org/entity/Q65398917> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q65398917 description "clinical trial" @default.
- Q65398917 description "ensayu clínicu" @default.
- Q65398917 description "klinisch onderzoek" @default.
- Q65398917 description "клінічне випробування" @default.
- Q65398917 description "կլինիկական փորձարկում" @default.
- Q65398917 name "NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients." @default.
- Q65398917 name "NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients." @default.
- Q65398917 type Item @default.
- Q65398917 label "NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients." @default.
- Q65398917 label "NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients." @default.
- Q65398917 prefLabel "NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients." @default.
- Q65398917 prefLabel "NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients." @default.
- Q65398917 P1132 Q65398917-FF9F2C8C-89CB-4B08-9040-54C22B51AC83 @default.
- Q65398917 P1476 Q65398917-CE88F1D2-2EE0-4DD7-A9D1-5400D0678E45 @default.
- Q65398917 P17 Q65398917-8284DB67-12CC-4A7A-AA9D-DD53AE1C3503 @default.
- Q65398917 P1813 Q65398917-057BF0D0-5451-4E89-9BA4-90D74CE4ACC6 @default.
- Q65398917 P2899 Q65398917-9B7A9338-1396-4EDB-B26A-650E4DE1D938 @default.
- Q65398917 P3098 Q65398917-658865BB-8F11-4EF2-B77E-49DBC3E06158 @default.
- Q65398917 P31 Q65398917-B06C993A-01C9-4556-9F7A-3736C0094610 @default.
- Q65398917 P4135 Q65398917-5C9C311A-B328-4901-8586-89F86F8B8120 @default.
- Q65398917 P4844 Q65398917-04840595-53AA-4378-AD6F-23BAEBE50F51 @default.
- Q65398917 P580 Q65398917-511A4965-98C0-4041-9073-5D039DBB6C4E @default.
- Q65398917 P582 Q65398917-55E145FD-B665-49E3-962D-1EE72347B0D6 @default.
- Q65398917 P6099 Q65398917-AC790D7E-B14D-4855-91DE-A2BCF337B951 @default.
- Q65398917 P6153 Q65398917-14195645-373D-46EB-B02A-0005D4AB38CE @default.
- Q65398917 P8363 Q65398917-98B65AD7-93B2-4587-BB11-7B0EC0AD41C1 @default.
- Q65398917 P859 Q65398917-4C6026FA-599D-4375-8894-62F32E668BFB @default.
- Q65398917 P1132 "+118" @default.
- Q65398917 P1476 "A 24-week, Open-label, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patchwith 1-step Titration in Patients With Mild to Moderate Alzheimer's Disease (MMSE 10 - 23) Switched Directly From Holinesterase Inhibitors (Donepezil, Galantamine)" @default.
- Q65398917 P17 Q17 @default.
- Q65398917 P1813 "ENA1stepswitch" @default.
- Q65398917 P2899 "+50" @default.
- Q65398917 P3098 "NCT02703636" @default.
- Q65398917 P31 Q30612 @default.
- Q65398917 P4135 "+85" @default.
- Q65398917 P4844 Q411887 @default.
- Q65398917 P580 "2016-05-09T00:00:00Z" @default.
- Q65398917 P582 "2018-05-07T00:00:00Z" @default.
- Q65398917 P6099 Q42825046 @default.
- Q65398917 P6153 Q507154 @default.
- Q65398917 P8363 Q78089383 @default.
- Q65398917 P859 Q507154 @default.